The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in Exosomes
Open accessAbstract
Monocyte-derived myeloid cells play vital roles in inflammation-related autoimmune/inflammatory diseases and cancers. Here, we report that exosomes can deliver anti-inflammatory agents, such as curcumin, to activated myeloid cells in vivo. This technology provides a means for anti-inflammatory drugs, such as curcumin, to target the inflammatory cells as well as to overcome unwanted off-target effects that limit their utility. Using exosomes as a delivery vehicle, we provide evidence that curcumin delivered by exosomes is more stable and more highly concentrated in the blood. We show that the target specificity is determined by exosomes, and the improvement of curcumin activity is achieved by directing curcumin to inflammatory cells associated with therapeutic, but not toxic, effects. Furthermore, we validate the therapeutic relevance of this technique in a lipopolysaccharide (LPS)-induced septic shock mouse model. We further show that exosomes, but not lipid alone, are required for the enhanced anti-inflammatory activity of curcumin. The specificity of using exosomes as a drug carrier creates opportunities for treatments of many inflammation-related diseases without significant side effects due to innocent bystander or off-target effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Aggarwal, B. B., & Harikumar, K. B. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.06.010 · Cited by 1,716
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, I. K., Rajasekharan, K. N., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.008 · Cited by 1,205
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035
Shaikh, J., Ankola, D. D., Beniwal, V., Singh, D., & Kumar, M. N. V. R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.019 · Cited by 956
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
Ravindran, J., Prasad, S., & Aggarwal, B. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9128-x · Cited by 768
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4174 · Cited by 755
Li, L., Braiteh, F. S., & Kurzrock, R. (2005) · Cancer · doi:10.1002/cncr.21300 · Cited by 644
Bhatnagar, S., Shinagawa, K., Castellino, F. J., & Schorey, J. S. (2007) · Blood · doi:10.1182/blood-2007-03-079152 · Cited by 633
Induction of myeloid‐derived suppressor cells by tumor exosomes
Xiang, X., Poliakov, A., Liu, C., Liu, Y., Deng, Z., Wang, J., Cheng, Z., Shah, S. V., Wang, G., Zhang, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24249 · Cited by 598
Self-citationInflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., & Ostrand-Rosenberg, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.284 · Cited by 539
Tumour-released exosomes and their implications in cancer immunity
Iero, M., Valenti, R., Huber, V, Filipazzi, P., Parmiani, G., Fais, S., & Rivoltini, L. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402237 · Cited by 485
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies
Epstein, J., Sanderson, I. R., & MacDonald, T. T. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509993667 · Cited by 464
King, I. L., Dickendesher, T. L., & Segal, B. M. (2009) · Blood · doi:10.1182/blood-2008-07-168575 · Cited by 444
Tumor exosomes inhibit differentiation of bone marrow dendritic cells
Yu, S., Liu, C., Su, K., Wang, J., Liu, Y., Zhang, L., Li, C., Cong, Y., Kimberly, R., Grizzle, W. E., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6867 · Cited by 425
Self-citationTumor-Released Microvesicles as Vehicles of Immunosuppression
Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G., & Rivoltini, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0520 · Cited by 409
Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems
Cui, J., Yu, B., Zhao, Y., Zhu, W., Li, H., Lou, H., & Zhai, G. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.009 · Cited by 395
CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis
Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K., & Khoury, S. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5228 · Cited by 370
Narayanan, N. K., Nargi, D., Randolph, C., & Narayanan, B. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24336 · Cited by 353
Jongstra-Bilen, J., Haidari, M., Zhu, S.-N., Chen, M., Guha, D., & Cybulsky, M. I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060245 · Cited by 330
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
Choi, H. S., Ipe, B. I., Misra, P., Lee, J. H., Bawendi, M. G., & Frangioni, J. V. (2009) · Nano Letters · doi:10.1021/nl900872r · Cited by 305
Boyd, J. H., Kan, B., Roberts, H., Wang, Y., & Walley, K. R. (2008) · Circulation Research · doi:10.1161/circresaha.107.167544 · Cited by 292
Bunt, S. K., Clements, V. K., Hanson, E. M., Sinha, P., & Ostrand-Rosenberg, S. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708446 · Cited by 277
Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury
Croce, K., Gao, H., Wang, Y., Mooroka, T., Sakuma, M., Shi, C., Sukhova, G. K., Packard, R. R. S., Hogg, N., Libby, P., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.814582 · Cited by 254
Myeloid heme oxygenase–1 regulates innate immunity and autoimmunity by modulating IFN-β production
Tzima, S., Victoratos, P., Kranidioti, K., Alexiou, M., & Kollias, G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081582 · Cited by 204
Nygren, J. M., Liuba, K., Breitbach, M., Stott, S., Thorén, L., Roell, W., Geisen, C., Sasse, P., Kirik, D., Björklund, A., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1721 · Cited by 171
Iwamoto, S., Iwai, S.-I., Tsujiyama, K., Kurahashi, C., Takeshita, K., Naoe, M., Masunaga, A., Ogawa, Y., Oguchi, K., & Miyazaki, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1449 · Cited by 163
Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis
Taylor, E., Megson, I. L., Haslett, C., & Rossi, A. G. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401152 · Cited by 154
Chen, C., Johnston, T. D., Jeon, H., Gedaly, R., McHugh, P. P., Burke, T. G., & Ranjan, D. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.009 · Cited by 150
Immature myeloid cells induced by a high-fat diet contribute to liver inflammation #
Deng, Z., Liu, Y., Liu, C., Xiang, X., Wang, J., Cheng, Z., Shah, S. V., Zhang, S., Zhang, L., Zhuang, X., et al. (2009) · Hepatology · doi:10.1002/hep.23148 · Cited by 149
Self-citationMedoff, B. D., Seung, E., Hong, S. J., Thomas, S. Y., Sandall, B. P., Duffield, J. S., Kuperman, D. A., Erle, D. J., & Luster, A. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.623 · Cited by 124
Li, J., Jiang, Y., Wen, J., Fan, G., Wu, Y., & Zhang, C. (2009) · Biomedical Chromatography · doi:10.1002/bmc.1244 · Cited by 105
Pais, T. F., Figueiredo, C., Peixoto, R. T., Braz, M. H., & Chatterjee, S. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-43 · Cited by 104
CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells
Beekhuizen, H., van Blokland, I. V., Tilburg, A. J. C.-V., Koning, F., & van Furth, R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3761 · Cited by 102
Yadav, V. R., Suresh, S., Devi, K., & Yadav, S. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.03.0005 · Cited by 102
Mulik, R. S., Mahadik, K. R., & Paradkar, A. R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.03.009 · Cited by 101
Regulation of monocytes and macrophages cell fate
González-Mejía, M. E. (2009) · Frontiers in bioscience · doi:10.2741/3387 · Cited by 93
Sasahara, M., Otani, A., Oishi, A., Kojima, H., Yodoi, Y., Kameda, T., Nakamura, H., & Yoshimura, N. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080024 · Cited by 82
Myeloid cells in atherosclerosis: initiators and decision shapers
Soehnlein, O., & Weber, C. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0141-z · Cited by 70
Xu, H., Manivannan, A., Dawson, R., Crane, I. J., Mack, M., Sharp, P., & Liversidge, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6915 · Cited by 65
Qu, P., Du, H., Li, Y., & Yan, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1648 · Cited by 55
Chen, K., Huang, J., Liu, Y., Gong, W., Cui, Y., & Wang, J. M. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.05.018 · Cited by 19
Self-citation
Cited by
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Extracellular vesicles as a next-generation drug delivery platform
Herrmann, I. K., Wood, M. J. A., & Fuhrmann, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00931-2 · Cited by 1,948
Vlassov, A. V., Magdaleno, S., Setterquist, R., & Conrad, R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.03.017 · Cited by 1,930
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,801
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Metadata
- Authors
- Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., Barnes, S., Grizzle, W., Miller, D., & Zhang, H.-G.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 18
- Issue
- 9
- Pages
- 1606-1614
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2166846320
- Cited by
- 1,572
- References
- 47
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.